1. Home
  2. SLDB vs FEIM Comparison

SLDB vs FEIM Comparison

Compare SLDB & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • FEIM
  • Stock Information
  • Founded
  • SLDB 2013
  • FEIM 1961
  • Country
  • SLDB United States
  • FEIM United States
  • Employees
  • SLDB N/A
  • FEIM N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • FEIM Electrical Products
  • Sector
  • SLDB Health Care
  • FEIM Industrials
  • Exchange
  • SLDB Nasdaq
  • FEIM Nasdaq
  • Market Cap
  • SLDB 124.7M
  • FEIM 129.3M
  • IPO Year
  • SLDB 2018
  • FEIM N/A
  • Fundamental
  • Price
  • SLDB $3.27
  • FEIM $16.99
  • Analyst Decision
  • SLDB Strong Buy
  • FEIM
  • Analyst Count
  • SLDB 12
  • FEIM 0
  • Target Price
  • SLDB $17.75
  • FEIM N/A
  • AVG Volume (30 Days)
  • SLDB 565.4K
  • FEIM 71.9K
  • Earning Date
  • SLDB 03-12-2025
  • FEIM 03-13-2025
  • Dividend Yield
  • SLDB N/A
  • FEIM 5.89%
  • EPS Growth
  • SLDB N/A
  • FEIM 183.83
  • EPS
  • SLDB N/A
  • FEIM 0.82
  • Revenue
  • SLDB N/A
  • FEIM $60,188,000.00
  • Revenue This Year
  • SLDB N/A
  • FEIM N/A
  • Revenue Next Year
  • SLDB N/A
  • FEIM N/A
  • P/E Ratio
  • SLDB N/A
  • FEIM $20.69
  • Revenue Growth
  • SLDB N/A
  • FEIM 21.33
  • 52 Week Low
  • SLDB $3.03
  • FEIM $8.62
  • 52 Week High
  • SLDB $15.05
  • FEIM $20.33
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 31.17
  • FEIM 49.73
  • Support Level
  • SLDB $3.03
  • FEIM $16.10
  • Resistance Level
  • SLDB $4.59
  • FEIM $17.53
  • Average True Range (ATR)
  • SLDB 0.32
  • FEIM 0.73
  • MACD
  • SLDB -0.04
  • FEIM -0.35
  • Stochastic Oscillator
  • SLDB 15.38
  • FEIM 26.65

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

Share on Social Networks: